Sterling Biotech Limited
Formerly | Pluto Exports & Consultants Limited |
|---|---|
| Public | |
| Traded as | BSE: 512299 NSE: STERLINBIO ISIN: INE324C01038 |
| ISIN | 🆔 |
| Industry | Pharmaceuticals |
| Founded 📆 | 23 March 1985 |
| Founder 👔 | |
| Headquarters 🏙️ | BKC, Mumbai, Maharashtra, India.[1] |
Area served 🗺️ | |
Key people | Nitin Sandesara (Chairman & MD) Chetan Sandesara (Joint MD) |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
| Footnotes / references [2] | |
Sterling Biotech (BSE: 512299) is a pharmaceutical company incorporated on 23rd March, 1985 as Pluto Exports & Consultants Limited in Mumbai. The company continues its operation as a producer of pharmaceutical and Neutraceutical Gelatin in India and Asia. SBL (“Sterling Biotech Limited”) is also engaged in the production of Dicalcium Phosphate (DCP) which is a derivative of Gelatin Manufacturing Process especially for the poultry-feed and fertiliser industry in India.
History
Sterling Biotech Limited (SBL) started its operation on 23rd March, 1985 in Mumbai as Pluto Exports & Consultants Limited. It obtained its Certificate of Commencement of Business in the same year on 19th April. Pluto Exports & Consultants Limited started as a trading company, thereafter changed its focus multiple times to reach a conclusion to continue as a pharmaceutical company. On 24th June, 1991, the company changed its name to Sterling Tea and Industries Limited. Again, the management changed their focus to Gelatin production as they saw opportunities in that sector. On March 29th, 1995, as a decision of the board of management and as part of a growth strategy, the company renamed itself as Sterling Biotech Limited (SBL)[3]
In 1995, SBL announced a technical collaboration with UK based “Croda Colloids Limited”. In 1997, SBL diversified into pharmaceutical grade Gelatin and came up with their first production facility at Karakhadi, Vadodara with an initial installed capacity of 2200 MT. By the end of July, 2000, the company expanded to 4000MT pa capacity and decided to exit from the Tea business completely due to slow growth and a high level of competition. In 2003, SBL started export of Gelatin and changed its symbol from 'STERLINTEA' to 'NSE: STERLINBIO'.
In 2004, SBL acquired the Gelatine business of Rallis India Limited for Rs. 47 crores. As of 2007, SBL commissioned its plant for the manufacturing of Co Enzyme Q1O (Co Q10) at its Masar plant in Vadodara, Gujarat. Masar Plant facility is an export oriented unit.
As at March 2007, Sterling Biotech commissioned its plant for the manufacture of Co Enzyme Q1O (Co Q10) at its Masar plant in Vadodara. With effect from 30th March, 2007, Titanic Investment and Consultants holds 1,276,000 equity shares (representing 0.56% equity capital of the Company). They are also the promoters group of the company.
Corporate Governance
SBL is managed by a team of board of directors. CMD Mr. Nitin Sandesara and his father Mr. J.C. Sandesara, nurtured the company since its inception in 1985.[4] Other members of the Board of Directors team include:
- Mr. Nitin Sandesara - Chairman and Managing Director
- Mr. Chetan Sandesara - Joint Managing Director
- Mr. Vilas D Joshi – Director
- Mr. P. B. Mehta – Director
- Mrs. Mayuri Patel – Director
- Mr. R. B. Dixit – Director
The Team of Board of Directors are managed by several Committees formed by the group company to streamline decision making within the group – The committees are:
- Audit committee
- Nomination & remuneration committee
- Stakeholders’ relationship committee
- Corporate social responsibility committee
Products
SBL have an API and Formulations manufacturing unit that manufactures their products in-house.
As per sources [5], SBL manufactures and sells Gelatin, Di calcium Phosphate and other Pharma products as compliant to Pharma grade. The company is known to offer Pharma products used for treatment of cancer and for various cardiovascular diseases. Some of them are as follows:
Oncology
- Doxorubicin and Idarubicin (Drugs used for chemotherapy).
- Daunorubicin (used in the treatment of acute lymphocytic and myelocytic leukemias).
- Imatinib, (Used in the treatment of various types of cancers.
- Epirubicin, (An anthracycline drug used in chemotherapy).
Cardiovascular
- Lovastatin, (An agent used for lowering cholesterol)
- Dacarbazine (used in the treatment of Hodgkin disease and malignant melanoma)
- Temozolamide, (Used in grade IV astrocytoma, It is an oral alkylating agent)
- Simvastatin, (Used in reducing high risk heart problems. It’s a lipid lowering agent)
- Zoledronic Acid,(A generic product with synthetic active pharmaceutical ingredients)
SBL also manufactures Gelatin mainly used for making Capsule caps
Other Affiliates
As a part of the Sandesara group, SBL is partnered with 4 other companies namely – Sterling Global Oil Resources Limited (SEEPCO), Sterling Gelatin, Sterling SEZ (Special Economic Zone), PMT Machines
References
- ↑ "Sterling Biotech Limited: Registered Office". Sterling Biotech Ltd.
- ↑ "Sterling Biotech Announces Fourth Quarter 2018 Results" (PDF). sterlingbiotech.in. Sterling Biotech. May 14, 2019. Retrieved December 31, 2018.
- ↑ "Sterling Biotech History".
- ↑ "Sterling Biotech Ltd People".
- ↑ "Company Overview".
Acquiring Rallis [1]; The Hindu Business line Company Info [2] ; Economic Times Company Overview [3], Bloomberg. 2019 Company management Team [4]; Management Team Discussions[5]; India Infoline Sterling Factsheet[6]; NSE India Sterling Biotech History[7]; Sterling Reports[8]; ND TV Sterling Biotech Reports[9]; Religare Sterling Biotech Limited [10]; Zauba Technologies and Data Services
This article "Sterling Biotech" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Sterling Biotech. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
